AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a ...
The pharma industry is always on the lookout for new therapeutic angles that might prove to be a competitive advantage. Ben Hargreaves outlines how oncology is a priority for research, and how ...
A new UK company, called BioOrbit, has been formed with the aim of developing hardware for the manufacture of pharmaceuticals in space. The start-up is focusing on the crystallisation of antibody ...
AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceutical.
AstraZeneca’s first-in-class pan-AKT inhibitor Truqap was unable to improve overall survival (OS) in a phase 3 trial in triple-negative breast cancer (TNBC), denting the prospects of the new drug.
The Institute for Clinical and Economic Review (ICER) has published its annual report on "unsupported" price increases for medicines that it says have added around $815 million to US drug spending.
The BBC's probe into Diary of a CEO has followed an increase in emphasis on health topics by Bartlett that, according to the broadcaster, has resulted in a big increase in viewers and subscribers for ...
Editas ended the third quarter with cash reserves of around $256 million, down from $318 million three months earlier. It said at the time that was enough to fund operations to the middle of 2026, but ...
Investors seemed to panic after the announcement, with a sell-off driving Keros' share price down 73%, reversing strong gains ...
While 2025 remains an unknown quantity, it’s clear that fundraisers and investors see the value in visiting London in ...
Private equity group Carlyle has joined forces with other investors on a €900 million-plus recapitalisation of UK drugmaker ...
The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...